• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整块切除术水平和垂直切缘对非肌肉浸润性膀胱癌的临床意义。

Clinical Significance of Horizontal and Vertical Margin of En Bloc Resection for Nonmuscle Invasive Bladder Cancer.

机构信息

Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Department of Pathology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

出版信息

J Urol. 2021 Aug;206(2):252-259. doi: 10.1097/JU.0000000000001735. Epub 2021 Mar 29.

DOI:10.1097/JU.0000000000001735
PMID:33780284
Abstract

PURPOSE

The primary advantage of en bloc resection of bladder tumors is to provide better diagnostic accuracy. However, the clinical significance of horizontal and vertical margin has not been demonstrated. We evaluated the clinical importance of surgical margins in patients who underwent en bloc resection of bladder tumors.

MATERIALS AND METHODS

We retrospectively analyzed the records of 140 consecutive patients who underwent en bloc resection of bladder tumors for nonmuscle invasive bladder cancer. We analyzed perioperative and oncological outcome, and compared patient demographics and recurrence-free survival for horizontal findings. The relationship between surgical margin and second transurethral resection outcome in pT1 bladder cancer was also analyzed.

RESULTS

Mean tumor diameter was 17.2±9.8 mm. Pathological stages were 93 cases in pTa and 47 cases in pT1. Diagnostic rates for the horizontal and vertical margins were 63% and 99%, respectively. The rates of sessile, carcinoma in situ, high grade, and pT1 tumors were significantly higher in the horizontal margin positive group (41) than in the negative group (47). There was no significant difference in 2-year recurrence-free survival based on horizontal margin findings (negative: 72.4%, positive: 75.4%, p=0.87). A second transurethral resection was performed in 31 of the 47 pT1 patients; pT1 residue was seen only in vertical margin positive cases, and 5 pTa/pTis residues at the transurethral resection scar were seen in 15 horizontal margin positive patients.

CONCLUSIONS

Horizontal margin positive findings were not associated with recurrence-free survival, but careful assessment is warranted regarding residue at the original site. A second transurethral resection should be considered in patients with horizontal and vertical margin positive pT1 bladder cancer.

摘要

目的

整块切除膀胱肿瘤的主要优势在于提供更好的诊断准确性。然而,水平和垂直切缘的临床意义尚未得到证实。我们评估了整块切除膀胱肿瘤的患者中手术切缘的临床重要性。

材料与方法

我们回顾性分析了 140 例连续接受整块膀胱肿瘤切除术治疗非肌层浸润性膀胱癌患者的记录。我们分析了围手术期和肿瘤学结果,并比较了水平切缘的患者人口统计学和无复发生存率。还分析了 pT1 膀胱癌中手术切缘与二次经尿道电切术结果的关系。

结果

平均肿瘤直径为 17.2±9.8mm。病理分期为 93 例 pTa 和 47 例 pT1。水平和垂直切缘的诊断率分别为 63%和 99%。水平切缘阳性组(41 例)的固有型、高级别和 pT1 肿瘤的发生率明显高于阴性组(47 例)(41)。根据水平切缘结果,2 年无复发生存率无显著差异(阴性:72.4%,阳性:75.4%,p=0.87)。47 例 pT1 患者中有 31 例接受了二次经尿道电切术;仅在垂直切缘阳性病例中可见 pT1 残留,在 15 例水平切缘阳性患者中有 5 例可见经尿道电切术瘢痕处的 pTa/pTis 残留。

结论

水平切缘阳性结果与无复发生存率无关,但应仔细评估原位残留情况。对于水平和垂直切缘阳性的 pT1 膀胱癌患者,应考虑二次经尿道电切术。

相似文献

1
Clinical Significance of Horizontal and Vertical Margin of En Bloc Resection for Nonmuscle Invasive Bladder Cancer.整块切除术水平和垂直切缘对非肌肉浸润性膀胱癌的临床意义。
J Urol. 2021 Aug;206(2):252-259. doi: 10.1097/JU.0000000000001735. Epub 2021 Mar 29.
2
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?整块切除术后是否需要对病理 T1 期膀胱癌进行重复经尿道切除术?
BJU Int. 2023 Feb;131(2):190-197. doi: 10.1111/bju.15760. Epub 2022 May 13.
3
Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer.整块经尿道切除诊断的固有层垂直侵犯是 pT1 膀胱癌进展的一个重要预测指标。
J Urol. 2021 Jun;205(6):1622-1628. doi: 10.1097/JU.0000000000001630. Epub 2021 Jan 27.
4
Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.膀胱肿瘤切除术:安全性、复发和组织病理学差异效果的更新系统评价和荟萃分析。
J Urol. 2022 Apr;207(4):754-768. doi: 10.1097/JU.0000000000002444. Epub 2022 Jan 21.
5
pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.整块切除膀胱肿瘤标本中 pT1 亚分类预测无进展生存期。
Arch Pathol Lab Med. 2024 May 1;148(5):573-580. doi: 10.5858/arpa.2023-0044-OA.
6
Clinical Outcomes of Reresection in Patients with High-Risk Nonmuscle-Invasive Bladder Cancer Treated with Transurethral Resection: A Retrospective Study with a 1-Year Follow-Up.高危非肌层浸润性膀胱癌经经尿道电切术治疗后再次切除的临床疗效:一项 1 年随访的回顾性研究。
J Endourol. 2021 Dec;35(12):1801-1807. doi: 10.1089/end.2021.0008.
7
Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.经尿道使用双极纽扣电极整块切除非肌层浸润性膀胱癌。
Int Urol Nephrol. 2018 Apr;50(4):619-623. doi: 10.1007/s11255-018-1830-0. Epub 2018 Feb 24.
8
Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor.经尿道整块切除(TURBO)是膀胱肿瘤病理分期的准确工具。
Int J Urol. 2010 Aug;17(8):708-14. doi: 10.1111/j.1442-2042.2010.02571.x. Epub 2010 Jun 9.
9
A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer.一项评估经尿道内镜下黏膜切除术联合整块切除术治疗非肌肉浸润性膀胱癌的安全性和有效性的初步研究。
BMC Urol. 2019 Jun 24;19(1):56. doi: 10.1186/s12894-019-0486-0.
10
Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes.光动力诊断辅助整块经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌:短期肿瘤学和功能结果。
J Endourol. 2021 Mar;35(3):319-327. doi: 10.1089/end.2020.0371. Epub 2020 Nov 3.

引用本文的文献

1
The Role of Morcellation in En Bloc Resection of Large Bladder Tumors.粉碎术在膀胱大肿瘤整块切除中的作用
Diagnostics (Basel). 2025 Mar 13;15(6):716. doi: 10.3390/diagnostics15060716.
2
An updated systematic review, meta-analysis, and trial sequential analysis of the efficacy and safety of en bloc transurethral resection vs. conventional transurethral resection for nonmuscle-invasive bladder tumor.整块经尿道切除术与传统经尿道切除术治疗非肌层浸润性膀胱肿瘤的疗效和安全性的最新系统评价、荟萃分析及试验序贯分析
Int J Surg. 2025 Apr 1;111(4):3061-3077. doi: 10.1097/JS9.0000000000002291.
3
A novel laser resection approach: efficacy of rotatable bi-channel en bloc resection of bladder tumor in a pilot in-vivo study.
一种新型的激光切除方法:在体内初步研究中,旋转双通道整块切除膀胱肿瘤的疗效。
Lasers Med Sci. 2024 Jul 22;39(1):188. doi: 10.1007/s10103-024-04147-3.
4
Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma.高甲基化 TAGMe 作为一种通用癌症特异性甲基化标志物及其在尿路上皮癌的诊断和复发监测中的应用。
J Transl Med. 2024 Jul 2;22(1):608. doi: 10.1186/s12967-024-05420-3.
5
Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group.专家关于膀胱癌激光治疗应用的建议:欧洲泌尿技术协会(ESUT)和泌尿外科手术与技术培训和研究(TRUST)组的综合指南。
World J Urol. 2024 Feb 14;42(1):79. doi: 10.1007/s00345-024-04786-9.
6
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.整块切除术与常规经尿道膀胱肿瘤切除术治疗 T1HG 膀胱癌:倾向评分匹配分析。
Ann Surg Oncol. 2023 Jun;30(6):3820-3828. doi: 10.1245/s10434-023-13227-7. Epub 2023 Mar 10.
7
Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective.非肌层浸润性膀胱癌的精准诊断与治疗——临床视角
Front Oncol. 2023 Jan 31;13:1042552. doi: 10.3389/fonc.2023.1042552. eCollection 2023.
8
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?整块切除术后是否需要对病理 T1 期膀胱癌进行重复经尿道切除术?
BJU Int. 2023 Feb;131(2):190-197. doi: 10.1111/bju.15760. Epub 2022 May 13.
9
En bloc transurethral resection of bladder tumors: A review of current techniques.整块经尿道膀胱肿瘤切除术:当前技术综述
Can Urol Assoc J. 2022 May;16(5):E287-E293. doi: 10.5489/cuaj.7539.